10x Genomics (TXG) Debt Ratio (2018 - 2019)
10x Genomics' (TXG) quarterly Debt Ratio came in at 0.05 in Q4 2019, down 79.45% year-on-year from 0.24 in Q4 2018, and down 5.37% quarter-over-quarter from 0.05 in Q3 2019.
10x Genomics (TXG) Debt Ratio (2018 - 2019) Analysis & Trends
10x Genomics has disclosed Debt Ratio across 2 years of filings, most recently posting 0.05 for Q4 2019.
- Debt Ratio for Q4 2019 came in at 0.05, down 79.45% year-over-year; the trailing twelve-month figure through Dec 2019 was 0.05 (down 79.45% YoY), and the FY2019 annual result was 0.05, down 79.45% from the prior year.
- Debt Ratio came in at 0.05 for Q4 2019 at 10x Genomics, down from 0.05 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.24 in Q4 2018 to a low of 0.05 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 0.40 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.29 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | - |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.25 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | - |
| 10 | Teladoc Health | 1.45 Bn | 696.57 Mn | 562.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.05 |
| Sep 30, 2019 | 0.05 |
| Dec 31, 2018 | 0.24 |